The Department of Cardiovascular & Metabolic Sciences is home to scientists with broad expertise in cardiovascular and related systems as well as cellular metabolism related to diabetes, cancer and heart disease.More About Us
Two distinct gut microbial enzyme pathways could be targeted in therapeutic development.
New study finds elevated levels of the metabolite phenylacetylglutamine are associated with increased risk of heart failure.
Cleveland Clinic researchers find that despite general benefits from fruits and vegetables, people need the right gut microbiota to reap the benefits from flavonoids.
Exciting investigation and groundbreaking discovery happens every day at Cleveland Clinic. Join our team of expert researchers at the Department of Cardiovascular & Metabolic Sciences.View Careers